细菌
全血
菌血症
血培养
抗生素
克
环介导等温扩增
微生物学
打字
革兰氏阳性菌
抗菌剂
革兰氏阴性菌
医学
鲍曼不动杆菌
头孢菌素
DNA提取
铜绿假单胞菌
生物
血流感染
微生物培养
临床微生物学
抗生素耐药性
革兰氏染色
作者
Katherine Koprowski,Jongwon Lim,An Bao Van,Matthew Wester,Tessa Waldhoff,Karen White,James Kumar,Enrique Valera,Rashid Bashir
出处
期刊:ACS Sensors
[American Chemical Society]
日期:2026-02-18
卷期号:11 (3): 2366-2375
标识
DOI:10.1021/acssensors.5c04177
摘要
Timely identification of bacteria in bloodstream infections is critical for guiding appropriate antibiotic treatment. However, current clinical workflows entail blood culture (1-5 days), followed by Gram staining, PCR, and antibiotic susceptibility testing. These steps delay actionable results, often leading clinicians to prescribe broad-spectrum antibiotics without results from the above tests, contributing to the rising threat of antimicrobial resistance. Specifically, rapid information of even presence of Gram-positive and/or Gram-negative bacteria would help clinicians choose a specific antibiotic regimen after bacteremia is suspected. Here, we developed a rapid, culture-free method that identifies bacterial Gram type within a panel of 6 bacteria from whole blood at a sensitivity of 1-5 CFU/μL within 1.5 h. The assay features a duplex probe-based detection of amplification by release of quenching (DARQ) loop-mediated isothermal amplification (LAMP) system targeting six of the most common bloodstream pathogens in blood cultures in published hospital reports. The two DARQ probes distinguish a panel of four Gram-negative bacteria (E. coli, S. marcescens, P. mirabilis, and K. pneumoniae) from two Gram-positive bacteria (methicillin-susceptible S. aureus/methicillin-resistant S. aureus and S. epidermidis). Coupled with our "biphasic" sample preparation technique (reported earlier) in a 4 μL sample volume, the assay could eliminate the need for blood culture, extraction & purification, providing Gram type information to guide clinical treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI